Connection

Jean-Charles Soria to Receptor Protein-Tyrosine Kinases

Back to Details
This is a "connection" page, showing publications Jean-Charles Soria has written about Receptor Protein-Tyrosine Kinases.
Jean-Charles Soria
Connection Strength
0.183
Receptor Protein-Tyrosine Kinases
  1. Circulating Tumor Cells with Aberrant ALK Copy Number Predict Progression-Free Survival during Crizotinib Treatment in ALK-Rearranged Non-Small Cell Lung Cancer Patients. Cancer Res. 2017 05 01; 77(9):2222-2230.
    View in: PubMed
    Score: 0.149
  2. Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT). Lancet. 2016 Apr 02; 387(10026):1415-1426.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.